Xiaoying Dong

Xiaoying Dong

Auto-generated profile, based on publicly available information

Xiaoying Dong

Duke University

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2019 in Journal of Immunology Research
Verified
Journal Article
Open access
DLDi Lu
Di Lu
ZNZhen Ni
Zhen Ni
XLXiguang Liu
Xiguang Liu
SFSiyang Feng
Siyang Feng
XDXiaoying Dong
Xiaoying Dong
KCKaican Cai
Kaican Cai
Programmed cell death protein 1 (PD-1) and its ligand PD-L1 have attracted wide attention from researchers in the field of immunotherapy. PD-1/PD-L1 have been shown to exist in many types of cells in addition to T lymphocytes, and studies have accordingly extended from their suppressive effect on T cell activation and function to examining their role in other cells. In this review, we summarize recent research on PD-1/PD-L1 in macrophages, with the aim of furthering our understanding of PD-1/PD-L1 and their detailed roles in macrophages. This information may provide additional insights for researchers, enrich the basic theory of anti-PD-1/PD-L1 immunotherapy, and thus ultimately benefit more patients.

1 January 2023
Verified
Book
Closed access
XDXiaoying Dong
Xiaoying Dong
YYYan Yu
Yan Yu
JZJiali Zhou
Jiali Zhou

18 June 2016
Verified
Book Chapter
Closed access
PDF file
APArlie O. Petters
Arlie O. Petters
XDXiaoying Dong
Xiaoying Dong

18 June 2016
Verified
Book Chapter
Closed access
PDF file
APArlie O. Petters
Arlie O. Petters
XDXiaoying Dong
Xiaoying Dong

18 June 2016
Verified
Book Chapter
Closed access
PDF file
APArlie O. Petters
Arlie O. Petters
XDXiaoying Dong
Xiaoying Dong

1 January 2021 in Complexity
Verified
Journal Article
Open access
PDF file
DLDi Lu
Di Lu
HWHe Wang
He Wang
XWXuanzhen Wu
Xuanzhen Wu
JZJianxue Zhai
Jianxue Zhai
XLXiguang Liu
Xiguang Liu
KCKaican Cai
Kaican Cai
Background. The aim of this study was to identify novel biomarkers associated with esophageal squamous cell carcinoma (ESCC) prognosis. Methods. 81 ESCC samples collected from The Cancer Genome Atlas (TCGA) were used as the training set, and 179 ESCC samples collected from the Gene Expression Omnibus database (GEO) were used as the validation set. The protein‐coding genes of 25 samples from patients who completed the follow‐up in TCGA were analyzed to construct a coexpression network by weighted gene coexpression network analysis (WGCNA). Gene ontology (GO) terms and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways analyses were performed for the selected genes. The least absolute shrinkage and selection operator (LASSO) Cox regression model was constructed to analyze survival‐related genes, and an optimal prognostic model was developed as well as evaluated by Kaplan–Meier and ROC curves. Results. In this study, a module containing 43 protein‐coding genes and strongly related to overall survival (OS) was identified through WGCNA. These genes were significantly enriched in retina homeostasis, antimicrobial humoral response, and epithelial cell differentiation. Besides, through the LASSO regression model, 3 genes (PDLIM2, DNASE1L3, and KRT81) significantly related to ESCC survival were screened and an optimal prognostic 3‐gene risk prediction model was constructed. ESCC patients with low and high OS in both sets could be successfully discriminated by calculating a risk score with the linear combination of the expression level of each gene multiplied by the LASSO coefficient. Conclusions. Our study identified three novel biomarkers that have potential in the prognosis prediction of ESCC.